|
Pneumococcal Immunization Table |
|
Pneumococcal Immunization, Adults (65+)
|
| Burden of Disease |
Mortality1
5,000 Americans die each year from invasive pneumococcal infections. More than half of these deaths are among adults over age 65. |
Morbidity1
40,000 Americans develop invasive pneumococcal infections each year. One-third of these infections occur among adults over age 65. |
| Effectiveness |
Efficacy of pneumococcal vaccine in reducing pneumococcal disease is 54%2 |
| Improvability |
Delivery Rates3
57% of adults 65+ have received a pneumococcal vaccination |
Guide to Community Preventive Services Recommendations4
Numerous interventions are effective at improving vaccination coverage including interventions to increase demand, enhance access and improve clinic systems. |
| Cost5 |
Annual Per Person Medical Cost of Service: $43 |
| Annual Per Person Medical Cost of Savings: $108 |
| Annual Net Costs: $-65 |
| % of Service Cost Recovered in Long Run: 251% |
Sources and Footnotes:
1. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report 2004, Emerging Infections Program Network, Streptococcus pneumoniae, 2003 provisional. http://www.cdc.gov/ncidod/dbmd/abcs/survreports.htm, last accessed April 10, 2006.
2. Refer to the technical report on pneumococcal vaccination for a fuller discussion of these data and references.
3. Public health and aging: influenza vaccination coverage among adults aged > or = 50 years and pneumococcal vaccination coverage among adults aged > or = 65 years--United States, 2002. MMWR Morb Mortal Wkly Rep 2003 Oct 17;52(41):987-92.
4. Guide to Community Preventive Services Website. http://www.thecommunityguide.org/vaccine/default.htm
5. Five notes on costs and savings: 1) Costs and savings are expressed in year 2005 dollars. 2) Costs and savings are expressed as the per person cost per year over the recommended age range to facilitate use in estimating long-term budget impact. 3) Costs and savings are not discounted to facilitate use in estimating long-term budget impact. As a result, they are not comparable to estimates that would be used in formal cost-effectiveness analysis. Services that are cost-saving from a budgetary perspective may not be cost-saving in an economic analysis that discounts future events to their present value. 4) Costs and savings reflect non-adherence and the recommended frequency of delivery. Therefore, services with less frequent intervals or with lower adherence would have a lower cost than an otherwise identical service. 5) Costs reflect both initial preventive service costs (such as screening and counseling) and necessary follow-up costs such as diagnostic testing, pharmacotherapy, and intensive interventions for weight loss.
|
